In contrast, reduced levels of MPIF-1/CCL23 in progressors suggest a disruption in granuloma formation, which facilitates disease progression—this finding diverges from previous studies (Li et al., 2023; Yang et al., 2023). Here, CCL23 is linked to Granuloma.